Overview of KAHF Technology: A solution for early stage Cancer Patients and Metastatic Patients.
KAHF Technology is capable of metastasis inhibition in early stage PDAC supported with extensive pre-clinical data and further sensitizes hard-to-treat metastatic tumor cells to standard-of-the-care therapy.